Clinical Benefits of a Blood Glucose Monitoring System in Patients With Type 2 Diabetes

Completed · Not applicable

Conditions studied: Diabetes Mellitus, Type 2

In brief

Clinical benefits of the OneTouch® Ultra®2 BGMS versus standard BGMS during 52 weeks of use.

Key facts

Study ID

NCT00401622

Run by

LifeScan

People needed

320

Starts

2006-10-01

Expected to finish

2009-01-01

Last updated by the study team

2019-05-15

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may not qualify if…

• Using insulin
• Using oral agents that target post-prandial hyperglycemia (Note: These medications may be added during the study)
• Known history of anemia or disorders associated with anemia
• Has previously used the devices being tested in the study

Where it is running

• Study site — Phoenix, Arizona, United States
• Study site — San Diego, California, United States
• Study site — Wilmington, Delaware, United States
• Study site — Hollywood, Florida, United States
• Study site — Dawsonville, Georgia, United States
• Study site — Whitehouse Station, New Jersey, United States
• Study site — East Syracuse, New York, United States
• Study site — Endwell, New York, United States
• Study site — Syracuse, New York, United States
• Study site — San Antonio, Texas, United States
• Study site — Oshawa, Ontario, Canada
• Study site — Windsor, Ontario, Canada
• Study site — Reading, Berkshire, United Kingdom
• Study site — Llanishen, Cardiff, United Kingdom
• Study site — Buckshaw Village, Chorley, United Kingdom
• Study site — Lloyd Street North, Manchester, United Kingdom
• Study site — Glasgow, Scotland, United Kingdom
• Study site — Claygate, Surrey, United Kingdom

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.